{"transactions":[{"id":742970,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39627,"kind":"person","name":"Clark Wesley","position":1,"cik":"0001349193","reported_name":"Clark Wesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T00:11:27.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":65600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2025 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 9, 2027 or the date immediately preceding the next annual meeting of stockholders."}],"balance_after":65600,"derivative":{"exercise_price":7.25,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":65600},"source":{"system":"sec-edgar","filing":"0001349193-26-000003","document":"wk-form4_1781136683.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000134919326000003/wk-form4_1781136683.xml","form_type":"4"}},{"id":1104891,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39627,"kind":"person","name":"Clark Wesley","position":1,"cik":"0001349193","reported_name":"Clark Wesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-20T22:34:19.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":162786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2025 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 18, 2026 or the date immediately preceding the Issuer's next annual meeting of stockholders."}],"balance_after":162786,"derivative":{"exercise_price":2.84,"expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":162786},"source":{"system":"sec-edgar","filing":"0001326110-25-000090","document":"wk-form4_1750458853.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000090/wk-form4_1750458853.xml","form_type":"4"}},{"id":1480432,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39627,"kind":"person","name":"Clark Wesley","position":1,"cik":"0001349193","reported_name":"Clark Wesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-13T22:49:51.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":77633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 11, 2025 or the date immediately preceding the next annual meeting of stockholders."}],"balance_after":77633,"derivative":{"exercise_price":5.96,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":77633},"source":{"system":"sec-edgar","filing":"0001326110-24-000080","document":"wk-form4_1718318985.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611024000080/wk-form4_1718318985.xml","form_type":"4"}},{"id":1854135,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39627,"kind":"person","name":"Clark Wesley","position":1,"cik":"0001349193","reported_name":"Clark Wesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T22:27:01.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":158263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 13, 2024 or the date immediately preceding the next annual meeting of stockholders."}],"balance_after":158263,"derivative":{"exercise_price":2.99,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":158263},"source":{"system":"sec-edgar","filing":"0001326110-23-000087","document":"wk-form4_1686868013.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000087/wk-form4_1686868013.xml","form_type":"4"}},{"id":1866714,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39627,"kind":"person","name":"Clark Wesley","position":1,"cik":"0001349193","reported_name":"Clark Wesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T23:54:46.000Z","date":"2023-06-01","kind":"purchase","planned":false,"acquired":true,"shares":7000,"price":2.91,"value":20370.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001326110-23-000070","document":"wk-form4_1686009278.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000070/wk-form4_1686009278.xml","form_type":"4"}},{"id":2231331,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39627,"kind":"person","name":"Clark Wesley","position":1,"cik":"0001349193","reported_name":"Clark Wesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T01:20:52.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":167937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 14, 2023 or the date immediately preceding the 2023 annual meeting of stockholders."}],"balance_after":167937,"derivative":{"exercise_price":2.98,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":167937},"source":{"system":"sec-edgar","filing":"0001326110-22-000049","document":"wf-form4_165534243897466.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611022000049/wf-form4_165534243897466.xml","form_type":"4"}},{"id":2669968,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39627,"kind":"person","name":"Clark Wesley","position":1,"cik":"0001349193","reported_name":"Clark Wesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-14T22:33:18.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":26064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 10, 2022 or the date immediately preceding the 2022 annual meeting of stockholders."}],"balance_after":26064,"derivative":{"exercise_price":14.91,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":26064},"source":{"system":"sec-edgar","filing":"0001209191-21-040347","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121040347/doc4.xml","form_type":"4"}},{"id":2726955,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":39627,"kind":"person","name":"Clark Wesley","position":1,"cik":"0001349193","reported_name":"Clark Wesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-05T22:03:42.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":21873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, the shares subject to the award will vest in three (3) equal installments on each of March 9, 2022, March 9, 2023 and March 9, 2024, such that the award will be fully vested March 9, 2024."}],"balance_after":21873,"derivative":{"exercise_price":17.24,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":21873},"source":{"system":"sec-edgar","filing":"0001209191-21-030443","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121030443/doc4.xml","form_type":"4"}}]}